Hualan Biological Bacterin Inc. (301207.SZ)
CNY 18.51
(0.16%)
CNY 18.51
(0.16%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.01 Billion CNY | 48.82% |
| 2022 | 592.63 Million CNY | -16.17% |
| 2021 | 706.97 Million CNY | -34.18% |
| 2020 | 1.07 Billion CNY | 148.61% |
| 2019 | 432.04 Million CNY | 44.11% |
| 2018 | 299.8 Million CNY | 398.23% |
| 2017 | -100.52 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 251.05 Million CNY | 690.72% |
| 2024 Q1 | 43.49 Million CNY | -81.78% |
| 2024 Q2 | -47.61 Million CNY | -209.49% |
| 2023 Q1 | 105.9 Million CNY | 550.89% |
| 2023 FY | 881.93 Million CNY | 48.82% |
| 2023 Q4 | 238.72 Million CNY | -60.95% |
| 2023 Q3 | 611.32 Million CNY | 2914.69% |
| 2023 Q2 | 20.27 Million CNY | -80.85% |
| 2022 Q3 | 239.14 Million CNY | -30.56% |
| 2022 Q2 | 344.38 Million CNY | 4908.68% |
| 2022 Q1 | -7.16 Million CNY | -106.89% |
| 2022 FY | 592.63 Million CNY | -16.17% |
| 2022 Q4 | 16.27 Million CNY | -93.2% |
| 2021 Q1 | -10.44 Million CNY | -101.75% |
| 2021 Q4 | 103.88 Million CNY | -84.03% |
| 2021 Q3 | 650.3 Million CNY | 1868.74% |
| 2021 Q2 | -36.76 Million CNY | -251.94% |
| 2021 FY | 706.97 Million CNY | -34.18% |
| 2020 FY | 1.07 Billion CNY | 148.61% |
| 2020 Q4 | 597.66 Million CNY | 16.72% |
| 2020 Q3 | 512.05 Million CNY | 7064.4% |
| 2020 Q2 | -7.35 Million CNY | 73.99% |
| 2020 Q1 | -28.26 Million CNY | 0.0% |
| 2019 FY | 432.04 Million CNY | 44.11% |
| 2018 FY | 299.8 Million CNY | 398.23% |
| 2017 FY | -100.52 Million CNY | 0.0% |